Pregnancy and ACE Inhibitors or ARBs: Fetal Risk and Safe Alternatives

When a woman finds out she’s pregnant, one of the first things her doctor checks is her blood pressure. High blood pressure during pregnancy isn’t just a concern for the mother-it can seriously harm the baby. And if she’s been taking an ACE inhibitor or ARB for high blood pressure before pregnancy, that’s a red flag that needs immediate attention. These drugs, commonly prescribed for hypertension, heart failure, or kidney disease, are dangerous during pregnancy. Not just risky. Not just “use with caution.” They’re outright contraindicated. The evidence is clear, consistent, and overwhelming: taking ACE inhibitors or ARBs while pregnant can lead to miscarriage, kidney failure in the fetus, low amniotic fluid, skull deformities, and even death.

Why ACE Inhibitors and ARBs Are Dangerous in Pregnancy

ACE inhibitors-like lisinopril, enalapril, and captopril-and ARBs-like losartan and candesartan-work by blocking the renin-angiotensin-aldosterone system (RAAS). That system helps regulate blood pressure in adults. But in a developing fetus, RAAS is essential for forming kidneys, producing amniotic fluid, and maintaining normal blood flow to the placenta. When these drugs block RAAS during pregnancy, the baby’s kidneys can’t develop properly. This leads to oligohydramnios-dangerously low levels of amniotic fluid. Without enough fluid, the baby’s lungs don’t mature, limbs can become compressed, and skull bones may fuse prematurely. The result? A condition known as fetal renin-angiotensin system blockade syndrome.

It’s not just structural damage. Babies exposed to these drugs in utero often have low birth weight, premature birth, and severe kidney failure after delivery. Some require dialysis right after birth. A 2011 study published in Obstetrics & Gynecology International found that pregnancies exposed to ACE inhibitors or ARBs had a 25.4% miscarriage rate, compared to 12.3% in matched controls. The same study showed babies exposed to these drugs were born an average of 1.8 weeks earlier and weighed 350 grams less than those not exposed. Even more alarming, a 2020 meta-analysis of 72 studies concluded that first-trimester exposure still increases the risk of adverse outcomes-debunking the old myth that early exposure is safe.

ARBs vs. ACE Inhibitors: Which Is Worse?

Both classes are dangerous. But research shows ARBs carry an even higher risk than ACE inhibitors. The American Heart Association’s 2012 review found that babies exposed to ARBs had poorer neonatal outcomes, including more severe kidney damage and higher rates of death. This isn’t a small difference-it’s clinically significant. Drugs like losartan and candesartan (ARBs) appear to cross the placenta more readily and have longer half-lives, meaning they stick around in the fetal system longer. ACE inhibitors like enalapril and lisinopril are still extremely risky, but ARBs are worse. That’s why guidelines now treat them as equally dangerous, but with a stronger warning for ARBs.

What Happens If You’re Already Pregnant and Taking One?

If you’re on an ACE inhibitor or ARB and just found out you’re pregnant, don’t panic-but act fast. Stop taking the medication immediately. Do not wait for your next appointment. Call your doctor today. The longer you take it, the greater the risk to the baby. The goal isn’t to replace it with another risky drug-it’s to switch to something proven safe during pregnancy. The two most commonly recommended alternatives are labetalol and methyldopa.

Labetalol is a beta-blocker that works on both alpha and beta receptors. It’s become the first-line choice because it’s effective, well-studied, and has minimal side effects on the fetus. Starting doses are usually 100 mg twice daily, and doctors can safely increase it up to 2,400 mg per day if needed. It doesn’t cross the placenta as much as other drugs, and it doesn’t interfere with fetal kidney development.

Methyldopa has been used since the 1970s and has the longest safety record in pregnancy of any antihypertensive. It’s a centrally acting drug that reduces blood pressure by calming the nervous system. It’s often prescribed at 250 mg twice daily, with doses increased up to 3,000 mg per day. It’s especially useful for women with chronic hypertension who need long-term control. It’s not flashy, but it’s reliable.

Another option is nifedipine, a calcium channel blocker. It’s used as a second-line treatment, especially for sudden spikes in blood pressure. But it’s not ideal for women with heart problems because it can weaken heart muscle contractions. Always use it under close supervision.

What About Other Blood Pressure Medications?

Not all blood pressure drugs are safe in pregnancy. Diuretics like hydrochlorothiazide can reduce blood volume too much and harm placental flow. Angiotensin receptor blockers (ARBs) are already ruled out. Beta-blockers like atenolol are avoided because they can restrict fetal growth. ACE inhibitors and ARBs are the only ones with a formal FDA boxed warning for fetal toxicity. Everything else is evaluated case by case. The bottom line: only labetalol, methyldopa, and sometimes nifedipine are considered first-choice options. Everything else carries unknown or higher risks.

What Should Women Planning Pregnancy Do?

Prevention is everything. If you’re a woman of childbearing age and take an ACE inhibitor or ARB for high blood pressure, talk to your doctor before trying to conceive. Don’t wait until you’re pregnant. Your provider should:

• Check if you’re pregnant before prescribing these drugs
• Ask if you’re planning to become pregnant
• Explain the risks clearly
• Switch you to a safer alternative before conception

The American College of Cardiology’s 2023 guideline says women on these drugs must receive counseling about teratogenic risks and the need for effective contraception. This isn’t optional. It’s standard care. And yet, according to FDA data from 2021, 1.2% of pregnancies in women with chronic hypertension still involve exposure to these drugs. That’s 1 in 80 cases. That’s unacceptable. Better counseling, better follow-up, and better awareness could prevent most of these cases.

Guidelines Agree: No Safe Trimester

Every major medical organization in the world agrees: there is no safe time to take an ACE inhibitor or ARB during pregnancy. Not in the first trimester. Not in the second. Not in the third.

• The American College of Obstetricians and Gynecologists (ACOG) says they’re contraindicated in all trimesters and must be stopped as soon as pregnancy is confirmed.
• The American Heart Association says there’s no safe trimester and calls for improved preconception counseling.
• Te Whatu Ora in New Zealand, the Society of Obstetricians and Gynaecologists of Canada, and the European Medicines Agency all echo the same warning.
• The World Health Organization doesn’t even list ACE inhibitors or ARBs on its Model List of Essential Medicines for pregnancy.

Even though some early studies suggested first-trimester exposure might be less risky, the weight of evidence now says otherwise. The 2020 meta-analysis by Buawangpong and others settled that debate: any exposure increases the risk of miscarriage, preterm birth, and low birth weight. The risk isn’t just to the baby’s organs-it’s to the entire pregnancy.

What to Do Now

If you’re on an ACE inhibitor or ARB and pregnant: stop immediately. Call your OB-GYN or primary care provider. Don’t try to switch on your own. You need a safe replacement, and you need monitoring. Blood pressure targets during pregnancy are <140/90 mmHg. Your provider will likely start you on labetalol or methyldopa and adjust based on your response.

If you’re planning pregnancy and on one of these drugs: schedule a preconception visit. Ask for a switch. Ask for contraception counseling. Ask for a referral to a maternal-fetal medicine specialist if you have complex hypertension. This isn’t just about avoiding birth defects-it’s about giving your future child the best possible start.

And if you’re a healthcare provider: make this part of your routine. Ask every woman of childbearing age: “Are you planning to get pregnant?” “Are you using contraception?” “Are you on an ACE inhibitor or ARB?” Don’t assume. Don’t wait. Document. Educate. Switch. Save lives.